pharmaphorum
JANUARY 21, 2022
Research led by UCLH, UCL and the Francis Crick Institute found that the booster dose successfully stimulates antibody levels that neutralise Omicron. Overall, antibody levels were nearly 2.5 The post Covid vaccine booster raises antibody levels in fight against Omicron appeared first on.
Scienmag
MAY 16, 2021
The fully human monoclonal antibody produced sustained reductions in triglyceride levels of up to 82 percent, depending on the patient’s genotype, while also lowering the […].
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Pharma Data
NOVEMBER 10, 2020
Although a few are out there, phosphorylated tau (P-tau) may enable even earlier and more accurate detection, according to Eli Lilly-associated researchers speaking at the Clinical Trials on Alzheimer’s Disease (CTAD) virtual conference in early November. Detection – a ruthenium-labeled isoform-specific anti-tau antibody.
The Pharma Data
SEPTEMBER 2, 2021
Transforming treatment of advanced cancers with antibody drug conjugates (ADCs). Durvalumab ± Tremelimumab + Platinum-Etoposide in 1L ES-SCLC: Exploratory Analysis of HLA Genotype and Survival in CASPIAN. Posters: P47 – Novel Therapeutics and Targeted Therapies – Clinical Trial in Progress. Antibody drug conjugates.
Drug Discovery World
MAY 29, 2024
The project will combine Oxford’s academic research capabilities with SpyBiotech’s proprietary SPYVLP platform technology to advance three vaccine candidates targeting EBV and test these in a Phase I clinical trial. We see a great need for a vaccine against EBV.”
The Pharma Data
APRIL 14, 2021
A global, randomized Phase 3 confirmatory clinical trial TROPiCS-04 (NCT04527991) is underway and is also intended to support global registrations. More information on TROPiCS-04 is available at [link]. About Trodelvy.
Expert insights. Personalized for you.
113 
Let's personalize your content